Clorox Company (The) (NYSE:CLX) has been given a consensus recommendation of “Hold” by the fourteen ratings firms that are currently covering the firm, Marketbeat reports. Three research analysts have rated the stock with a sell recommendation, nine have assigned a hold recommendation and two have issued a buy recommendation on the company. The average 12-month price objective among brokerages that have issued a report on the stock in the last year is $125.42.

A number of equities research analysts recently issued reports on CLX shares. Zacks Investment Research lowered Clorox Company (The) from a “hold” rating to a “sell” rating in a research note on Wednesday, October 4th. BidaskClub lowered Clorox Company (The) from a “hold” rating to a “sell” rating in a research note on Wednesday, July 5th. Jefferies Group LLC reissued a “hold” rating and set a $132.00 price target (down from $137.00) on shares of Clorox Company (The) in a research note on Friday, October 6th. Deutsche Bank AG reissued a “hold” rating and set a $137.00 price target (up from $126.00) on shares of Clorox Company (The) in a research note on Saturday, July 22nd. Finally, BMO Capital Markets reissued a “buy” rating and set a $150.00 price target on shares of Clorox Company (The) in a research note on Thursday, October 5th.

In other Clorox Company (The) news, EVP James E. Foster sold 9,861 shares of Clorox Company (The) stock in a transaction on Wednesday, August 23rd. The stock was sold at an average price of $138.51, for a total transaction of $1,365,847.11. Following the completion of the sale, the executive vice president now directly owns 22,069 shares of the company’s stock, valued at approximately $3,056,777.19. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, SVP Jon M. Balousek sold 9,223 shares of Clorox Company (The) stock in a transaction on Wednesday, August 23rd. The shares were sold at an average price of $138.87, for a total value of $1,280,798.01. Following the sale, the senior vice president now directly owns 20,614 shares of the company’s stock, valued at $2,862,666.18. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 21,242 shares of company stock valued at $2,944,449. 1.00% of the stock is currently owned by corporate insiders.

Hedge funds and other institutional investors have recently modified their holdings of the business. Synovus Financial Corp raised its position in Clorox Company (The) by 14.5% during the 2nd quarter. Synovus Financial Corp now owns 8,786 shares of the company’s stock valued at $1,173,000 after purchasing an additional 1,114 shares in the last quarter. OMERS ADMINISTRATION Corp bought a new stake in Clorox Company (The) during the 2nd quarter valued at $2,184,000. Northwestern Mutual Wealth Management Co. raised its position in Clorox Company (The) by 3.2% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 44,974 shares of the company’s stock valued at $5,992,000 after purchasing an additional 1,399 shares in the last quarter. Ameriprise Financial Inc. raised its position in Clorox Company (The) by 24.6% during the 2nd quarter. Ameriprise Financial Inc. now owns 1,341,272 shares of the company’s stock valued at $178,433,000 after purchasing an additional 265,200 shares in the last quarter. Finally, Great Lakes Advisors LLC raised its position in Clorox Company (The) by 3.3% during the 2nd quarter. Great Lakes Advisors LLC now owns 5,970 shares of the company’s stock valued at $795,000 after purchasing an additional 192 shares in the last quarter. 71.30% of the stock is owned by institutional investors and hedge funds.

ILLEGAL ACTIVITY NOTICE: This piece was posted by American Banking News and is owned by of American Banking News. If you are reading this piece on another site, it was stolen and reposted in violation of U.S. and international copyright & trademark legislation. The legal version of this piece can be read at https://www.americanbankingnews.com/2017/10/26/clorox-company-the-clx-receives-average-recommendation-of-hold-from-brokerages.html.

Shares of Clorox Company (NYSE:CLX) traded up 1.14% during trading on Thursday, hitting $128.54. The company had a trading volume of 507,551 shares. Clorox Company has a 52 week low of $111.24 and a 52 week high of $141.76. The stock’s 50-day moving average price is $131.66 and its 200 day moving average price is $134.03. The company has a market capitalization of $16.59 billion, a P/E ratio of 24.09 and a beta of 0.39.

Clorox Company (The) (NYSE:CLX) last issued its quarterly earnings results on Thursday, August 3rd. The company reported $1.53 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.49 by $0.04. Clorox Company (The) had a return on equity of 190.67% and a net margin of 11.74%. The firm had revenue of $1.65 billion during the quarter, compared to analyst estimates of $1.65 billion. During the same period last year, the company earned $1.30 EPS. Clorox Company (The)’s quarterly revenue was up 2.9% compared to the same quarter last year. On average, equities research analysts forecast that Clorox Company will post $5.64 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Monday, November 13th. Shareholders of record on Wednesday, October 25th will be given a dividend of $0.84 per share. This represents a $3.36 dividend on an annualized basis and a yield of 2.64%. The ex-dividend date of this dividend is Tuesday, October 24th. Clorox Company (The)’s dividend payout ratio (DPR) is presently 63.04%.

Clorox Company (The) Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Analyst Recommendations for Clorox Company (The) (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.